Indefinite Delivery Contract SPE2DB20D7066

This indefinite delivery contract was awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corporation as a single award contract vehicle for the procurement of pharmaceutical products and medical supplies. The contract utilizes firm fixed price and delivery order terms, with a period of performance from July 16, 2020 through December 31, 2025 and potential value of $999,999,999. Task orders described in the solicitation involve the delivery of various prescription drugs, vaccines, intravenous solutions and medical consumables to Defense Logistics Agency locations for use in supporting Department of Defense health programs. Orders displayed a range of completion dates from September 2023 through October 2023 and place of performance in Conshohocken, Pennsylvania at Amerisourcebergen's corporate facility. No set-aside provisions or subcontractors were identified in the majority of task orders summarized.

The Defense Logistics Agency is responsible for providing worldwide logistics support to the Department of Defense, including procurement and distribution of medical supplies and pharmaceuticals to military treatment facilities and beneficiaries. The task orders awarded against this contract vehicle align with the agency's mission to ensure necessary medical resources and prescription medications are available to support military readiness and health services. The indefinite delivery contract mechanism and resulting delivery orders indicate the Defense Logistics Agency aims to utilize a prime vendor arrangement with Amerisourcebergen Drug Corporation to streamline procurement of critical pharmaceutical and medical consumable supplies on an as-needed basis.